| Document Date: 2014-11-25 04:40:36
Open Document File Size: 671,03 KBShare Result on Facebook
City London / / Company Johnson & Johnson / Janssen Pharmaceutica NV / The Deloitte Health Economics Group / Janssen Pharmaceutical Companies / / Continent Europe / / Country United States / / Event Company Expansion / / IndustryTerm consumer electronics / defined products / tangible product / biotechnology / pharmaceutical industry / aircraft manufacturing industries / healthcare delivery / healthcare cost-effectiveness / generic pharmaceutical industries / biopharmaceutical sector / biopharmaceutical medicines / aircraft manufacturing / pharmaceutical / healthcare / asset management / healthcare systems / biopharmaceutical industry / value chain / life-changing treatment solutions / food / biopharmaceutical business model / healthcare environment / biopharmaceutical / relentless search / biopharmaceutical firms / biopharmaceutical business environment / business communications / aircraft manufacturing industry / generic pharmaceutical / chemical entities / banking / food manufacturing / biopharmaceutical industry deals / pharmaceutical products / biopharmaceutical innovation / automotive manufacturing / biopharmaceutical research / / MedicalCondition priority diseases / acute diseases / disease / demographic and chronic degenerative diseases / Ebola / diseases / infectious diseases / chronic diseases / infection / / MedicalTreatment vaccination / / Organization Transcelerate Biopharma / / Person Madeleine Albright / / Position driver / player / Secretary of State / Chairman Jane Griffiths Company Group / advocate / Executive / Africa Executive / / Region Middle East / / Technology biotechnology / drug discovery / / URL www.janssenhealthpolicycentre.com / /
SocialTag |
High value, high uncertainty: Measuring risk in biopharmaceutical research and other industries Investing in the future of health other industries